Postoperative Recovery with Bispectral Index versus Anesthetic Concentration–guided Protocols
Fritz, Bradley A. B.S.*; Rao, Preetika B.A., B.S.*; Mashour, George A. M.D., Ph.D.†; Abdallah, Arbi ben Ph.D.‡; Burnside, Beth A. B.A.§; Jacobsohn, Eric M.B., Ch.B.‖; Zhang, Lini M.D.#; Avidan, Michael S. M.B.B.Ch.**
Background: Use of the bispectral index (BIS) monitor has been suggested to decrease excessive anesthetic drug administration, leading to improved recovery from general anesthesia. The purpose of this substudy of the B-Unawareand BAG-RECALL trials was to assess whether a BIS-based anesthetic protocol was superior to an end-tidal anesthetic concentration–based protocol in decreasing recovery time and postoperative complications.
Methods: Patients at high risk for awareness were randomized to either BIS-guided or end-tidal anesthetic concentration–guided general anesthesia in the original trials. Outcomes included time to postanesthesia care unit discharge readiness, time to achieve a postoperative Aldrete score of 9–10, intensive care unit length of stay, postoperative nausea and vomiting, and severe postoperative pain. Univariate Cox regression and chi-square tests were used for statistical analyses.
Results: The BIS cohort was not superior in time to postanesthesia care unit discharge readiness (hazard ratio, 1.0; 95% CI, 1.0–1.1; n = 2,949), time to achieve an Aldrete score of 9–10 (hazard ratio, 1.2; 95% CI, 1.0–1.4; n = 706), intensive care unit length of stay (hazard ratio, 1.0; 95% CI, 0.9–1.1; n = 2,074), incidence of postoperative nausea and vomiting (absolute risk reduction, −0.5%; 95% CI, −5.8 to 4.8%; n = 789), or incidence of severe postoperative pain (absolute risk reduction, 4.4%; 95% CI, −2.3 to 11.1%; n = 759).
Conclusions: In patients at high risk for awareness, the BIS-guided protocol is not superior to an anesthetic concentration–guided protocol in time needed for postoperative recovery or in the incidences of common postoperative complications.
What We Already Know about This Topic
* Whether use of bispectral index monitoring speeds recovery from surgery compared to routine clinical practice is controversial
What This Article Tells Us That Is New
* In a secondary analysis of nearly 3,000 patients at high risk of awareness randomized to anesthetic titration by bispectral index monitoring or an end-tidal anesthetic concentration protocol, groups did not differ in time to postanesthesia care unit discharge, time to achieve an Aldrete score of 9–10, or the incidence of postoperative nausea or vomiting or severe pain
RECOVERY from anesthesia is a critical perioperative period from the perspective of both physiologic stability and patient satisfaction. Postoperative nausea and vomiting (PONV) and severe pain are two of the most common outcomes reported during this period1
and are among the most distressing for patients.2
Furthermore, faster recovery can accelerate operating room turnover and reduce labor costs in the postanesthesia care unit (PACU).3
Thus, delayed or complicated recovery from general anesthesia can have a considerable impact on patient safety, patient satisfaction, recovery room resources, and costs of patient care.
The bispectral index (BIS) processed electroencephalogram has frequently been investigated as a candidate depth-of-anesthesia monitor intended to decrease the incidence of intraoperative awareness and to reduce excessive anesthetic drug administration. Targeting the appropriate anesthetic dose to an individual may lead to reduced incidence of delayed or complicated recovery.4–12
The B-Aware study was a multicenter, randomized, controlled trial in which patients at high risk for intraoperative awareness were anesthetized using either a BIS monitor or routine monitoring of clinical signs, with the primary outcome being intraoperative awareness.13
Patients randomized to BIS monitoring had a 1-min shorter median time to eye opening and a 3-min shorter median time to PACU discharge.4
The authors noted that this difference was statistically significant but clinically modest. In contrast, a meta-analysis conducted by the Cochrane Database of Systematic Reviews reports that BIS monitoring during surgery is associated with shorter PACU length of stay.5
A large trial in which BIS was used according to clinical discretion,6
an audit of surgery before and after the introduction of universal BIS monitoring,7
and a meta-analysis of ambulatory surgery patients8
all found that BIS monitoring was associated with a decreased incidence of PONV. The effect on postoperative pain is unclear, with one study finding that BIS monitoring is associated with lower postoperative pain scores9
and another finding no effect.10
Titrating adjunctive sedative–hypnotic infusions to higher BIS values during spinal anesthesia has been associated with a reduced incidence of postoperative delirium,10
which in turn has been linked to a shortened length of stay in the intensive care unit (ICU).11
Despite the inconsistent effects on these outcomes reported in various studies, it has been proposed that it is justified to use the BIS in every general anesthetic.14
clinical trials found that a BIS-based anesthetic protocol was not superior to an end-tidal anesthetic concentration (ETAC)–based protocol for preventing intraoperative awareness in patients at high risk for awareness. The difference between these trials and the previously discussed B-Aware trial is that these studies compared a BIS-based protocol to an ETAC-based protocol, whereas the B-Aware study compared a BIS-based protocol to routine clinical practice. The current investigation is a prespecified substudy of the B-Unaware and BAG-RECALL trials. The aim of this substudy was to determine whether, in patients at high risk for awareness, the BIS-based anesthetic protocol was superior to the ETAC-based protocol used in these trials in relation to postanesthesia recovery times, the incidence of PONV, and the incidence of severe postoperative pain.
Materials and Methods
The B-Unaware and BAG-RECALL trials included adult patients at high risk for intraoperative awareness who underwent surgery with general anesthesia using a potent volatile anesthetic agent.15
Patients were classified as being at high risk for intraoperative awareness if they had one or more of the following risk factors: preoperative long-term use of anticonvulsants, opiates, benzodiazepines, or cocaine; cardiac ejection fraction less than 40%; history of awareness with recall; history of difficult intubation or anticipated difficult intubation; American Society of Anesthesiologists physical status IV or V; aortic stenosis; end-stage lung disease; marginal exercise tolerance not resulting from musculoskeletal dysfunction; pulmonary hypertension; planned open-heart surgery; and daily alcohol consumption. Patients were enrolled in the B-Unaware trial from August 2005 through September 2006 at Washington University in St. Louis. Patients were enrolled in the BAG-RECALL trial from March 2008 through April 2010 at Washington University in St. Louis, the University of Chicago, and the University of Manitoba (Winnipeg, Manitoba, Canada). This substudy includes patients from the St. Louis site only. Patients who were transferred from the operating room to the ICU were excluded, except for the analysis of ICU length of stay. Patients who were transferred from the operating room to the PACU and subsequently sent to the ICU were excluded from the analyses of time to PACU discharge readiness and time to achieve an Aldrete score of 9–10. Data on PONV, severe postoperative pain, and time to reach an Aldrete score of 9–10 were available only for patients who were enrolled after an electronic medical record system was implemented in the PACU at Washington University in September 2009. The Human Research Protection Office at Washington University School of Medicine approved this study, and patients provided written informed consent for inclusion in either the B-Unaware or the BAG-RECALL trial.
In brief, patients in the B-Unaware and BAG-RECALL trials were electronically randomized in blocks of 100 to receive general anesthesia based either on an ETAC-guided protocol or a BIS-guided protocol. The patients, PACU staff, ICU staff, and study personnel were blinded with respect to group allocation. BIS values were obtained using the BIS Quatro Sensor (Covidien, Boulder, CO). In the ETAC-guided protocol, an alarm sounded when the ETAC went outside the target range of 0.7–1.3 times the age-adjusted minimum alveolar concentration. Age-adjustment was performed using charts published by Nickalls and Mapleson.17
BIS values were not displayed for patients randomized to the ETAC-based protocol, but were recorded. In the BIS-guided protocol, an alarm sounded when the BIS went outside the target range of 40–60; ETAC values were available during these operations. BIS values and ETAC values were recorded at minimum intervals of 1 min by means of electronic recording of anesthesia data with the use of MetaVision software (iMDsoft, Needham, MA), by direct electronic transfer of data to Microsoft Excel (Microsoft Corp., Redmond, WA), or by direct electronic transfer of data with the use of TrendFace Solo® software (ixellence GmbH, Wildau, Germany). These data were used to determine the median ETAC and BIS values during the maintenance period of surgery, excluding induction and emergence. Manual records of anesthesia and digital photographs of monitor trends were used as alternative sources of data in the rare instances that the computer data or the electronic anesthesia records were incomplete.
The outcome measures of the current study included time to PACU discharge readiness, time to achieve an Aldrete score greater than or equal to 9, ICU length of stay, PONV in the PACU, and severe postoperative pain in the PACU. Table 1
provides a description of the Aldrete score.18
Some patients were excluded from the analyses of certain outcomes, as described in the previous section. PACU discharge readiness was assessed by the PACU attending physician based on the following criteria: the patient was hemodynamically stable, had an Aldrete score greater than or equal to 9, had no nausea or vomiting, and had well-controlled pain. While in the PACU, patients were closely monitored by nurses (two patients per nurse). When the nurse felt the patient was ready for discharge, he or she activated a signal for the PACU resident to evaluate the patient. If the resident agreed, the attending physician assessed the patient. Time to achieve an Aldrete score greater than or equal to 9 was measured from the time of application of dressings to the surgical site and was recorded by the PACU nurse. ICU length of stay was defined as the time from ICU admission to ICU discharge. PONV was determined by documented nurse observation or administration of antiemetics in the PACU. Pain was assessed approximately every 10 min using the numerical rating system, and patients who reported a pain score of 8 or greater within 60 min after PACU admission were considered to have severe postoperative pain.19
All statistical analyses were performed using SPSS version 19 (IBM Corp., Armonk, NY). The preoperative and perioperative characteristics of the ETAC and BIS cohorts were compared using chi-square tests or Mann-Whitney U tests as appropriate. Differences in time to PACU discharge readiness, time to achieve an Aldrete score of 9–10, and ICU length of stay between the two groups were compared using univariate Cox regressions, whereas differences in incidence of PONV and severe postoperative pain were compared using chi-square analysis. Differences in the time-based endpoints are presented as hazard ratios, which indicate how much more likely a patient in the BIS group is to achieve the outcome of interest at any given time point, compared to a patient in the ETAC group. For these outcomes, the absolute risk reduction for a patient in the group experiencing prolonged recovery (time greater than the 90th percentile) and the associated number needed to treat were also determined. Differences in the incidence of PONV and severe postoperative pain are presented as absolute risk reduction (ARR) and number needed to treat (NNT). As a measure of precision, a 95% CI was calculated for each hazard ratio, ARR, and NNT presented.
To account for the potential interaction effects among covariates known to impact postoperative recovery, multivariate Cox proportional hazards regression and multivariate logistic regression were performed. All predictors were entered into the multivariate analyses without the use of univariate analyses to filter out insignificant variables.20
If values for any of the predictor variables were missing for a patient, that patient was excluded from the multivariate regression; no missing values were imputed. Values of P
< 0.05 were considered to be significant. To test the overall goodness-of-fit or calibration of the resulting models, the likelihood ratio was evaluated for the Cox regressions and the Hosmer-Lemeshow test was assessed for the logistic regressions. In addition, the C statistic was used to provide a measure of the ability of each logistic regression model to discriminate between those patients who experienced PONV and severe postoperative pain versus
those who did not.
In addition to BIS or ETAC group randomization, 12 variables were included in the multivariate analyses based on their importance in past studies. Patient variables included sex,4
and American Society of Anesthesiologists physical status.4
Smoking status was included as a dichotomous variable indicating whether the patient self-identified as a current smoker. Age was included as a continuous variable, not rounded to the nearest year. Perioperative factors included length of surgery,4
intraoperative administration of opiates,35
neuromuscular blockers, neostigmine,36
Opiate doses were converted to morphine equivalents using equianalgesic conversion factors published in the Alberta Hospice Palliative Care Resource Manual 38
and then normalized by patient weight. Neuromuscular blocker doses were converted to vecuronium equivalents using 95% effective doses (ED95) published in Cusick’s Anesthesia & Critical Care Reference Sheet 39
and then normalized by patient weight. Antiemetic doses were converted to ondansetron equivalents using usual doses presented in a review by Golembiewski et al.40
and then normalized by patient weight. In addition, a variable was created to indicate whether the identity of the surgical procedure placed the patient at high risk for delayed postoperative recovery. Abdominal, thoracic, and orthopedic procedures were identified as having high risk for delayed recovery because these operations have previously been associated with the longest mean PACU length of stay32
and the highest incidence of postoperative pain.31
The product of median ETAC and length of surgery was also included as a measure of cumulative anesthetic dose, and the median BIS value was included as a surrogate measure of average anesthetic depth.
Of the 1,931 B-Unaware patients and 4,700 BAG-RECALL patients for whom data were available, 5,884 patients were included in this substudy (fig. 1
). Time to PACU discharge readiness was measured in 2,949 patients who were transferred from the operating room to the PACU and were not subsequently sent to the ICU. Time to achieve an Aldrete score of 9 was measured in 706 patients who were transferred from the operating room to the PACU and were not subsequently sent to the ICU and who entered the study after an electronic medical record was implemented in the PACU in September 2009. ICU length of stay was measured in 2,074 patients who were transferred from the operating room to the ICU. PONV was assessed in 789 patients and severe postoperative pain was assessed in 759 patients who were transferred from the operating room to the PACU and were enrolled after an electronic medical record was implemented in the PACU in September 2009. A small number of patients who had been assigned to the BIS- or ETAC-based protocol received regional anesthesia or total IV anesthesia instead, as indicated in the original B-Unaware and BAG-RECALL publications.15
These patients were excluded from the analysis. No patient assigned to the BIS-based protocol was treated following the ETAC-based protocol, and vice versa
. The preoperative and perioperative characteristics of the patients who were admitted to the PACU but were not subsequently transferred to the ICU are shown in table 2
. The patients randomized to the BIS- and ETAC-based protocols did not differ with respect to any of the variables tested. The patients who were admitted to the ICU exhibited similar characteristics.
The unadjusted hazard ratio for a patient in the BIS group being ready for discharge from the PACU was 1.045 (95% CI, 0.972–1.124; P
= 0.232) (fig. 2A
). Of the 2,949 patients assessed, 139 patients in the BIS group (9.5%) and 156 patients in the ETAC group (10.6%) experienced a prolonged time (>228 min) to PACU discharge readiness. This represents an ARR of 1.1% (95% CI, −1.0 to 3.3%) and an NNT to benefit (NNTB) of 90 (95% CI: NNTB, 30–∞; NNT to harm [NNTH], ∞–94). The unadjusted hazard ratio for a patient in the BIS group, compared with a patient in the ETAC group, achieving an Aldrete score of 9–10 was 1.164 (95% CI, 0.976–1.389; P
= 0.091) (fig. 2B
). Of the 706 patients assessed, 36 patients in the BIS group (9.9%) and 35 patients in the ETAC group (10.1%) experienced prolonged time to achieve an Aldrete score of 9–10 (>190 min). This represents an ARR of 0.2% (95% CI, −4.3 to 4.6%) and an NNTB of 579 (95% CI: NNTB, 22–∞; NNTH, ∞–23). The unadjusted hazard ratio for a patient in the BIS group being discharged from the ICU was 1.002 (95% CI, 0.918–1.092; P
= 0.972) (fig. 2C
). Of the 2,074 patients assessed, 109 patients in the BIS group (10.3%) and 100 patients in the ETAC group (9.9%) experienced prolonged ICU length of stay (>9 days). This represents an ARR of −0.4% (95% CI, −3.0 to 2.2%) and an NNTH of 261 (95% CI: NNTB, 45–∞; NNTH, ∞–34).
There was no significant association between BIS/ETAC randomization and PONV (chi-square test with 1 degree of freedom = 0.031, P = 0.860). Of the 789 patients assessed, 70 patients in the BIS group (17.9%) and 69 patients in the ETAC group (17.4%) experienced PONV. This is an ARR of −0.5% (95% CI, −5.8 to 4.8%) and represents an NNTH of 209 (95% CI: NNTB, 20–∞; NNTH, ∞–17). There was no significant association between BIS or ETAC randomization and severe postoperative pain (chi-square test with 1 degree of freedom = 1.643, P = 0.200). Of the 759 patients assessed for severe postoperative pain, 120 patients in the BIS group (31.4%) and 135 patients in the ETAC group (35.8%) experienced severe pain. This is an ARR of 4.4% (95% CI, 2.3–11.1%) and represents an NNTB of 22 (95% CI: NNTB, 9–∞; NNTH, ∞–43).
After adjusting for patient characteristics and perioperative variables known to have an impact on postoperative recovery, there was still no difference between the BIS and ETAC cohorts with respect to any of the outcomes measured. The multivariate Cox regression for time to PACU discharge readiness included 1,193 patients (table 3
). The adjusted hazard ratio for a patient in the BIS group, compared with a patient in the ETAC group, being ready for discharge from the PACU was 1.086 (95% CI, 0.968–1.218). The Cox regression model had a highly significant likelihood ratio characteristic of 164 on 13 degrees of freedom (P
< 0.0001). The Cox multivariate regression for time to achieve an Aldrete score of 9–10 included 561 patients (table 3
). The adjusted hazard ratio for a patient in the BIS group, compared with a patient in the ETAC group, achieving an Aldrete score of 9–10 was 1.137 (95% CI, 0.932–1.387). The Cox regression model had a highly significant likelihood ratio characteristic of 92 on 13 degrees of freedom (P
< 0.0001). The multivariate Cox regression for ICU length of stay included 1,098 patients (table 3
). The adjusted hazard ratio for a patient in the BIS group, compared with a patient in the ETAC group, being discharged from the ICU was 0.981 (95% CI, 0.870–1.106). The Cox regression model had a highly significant likelihood ratio characteristic of 101 on 12 degrees of freedom (P
The multivariate logistic regression for PONV included 627 patients (table 4
). The adjusted odds ratio for a patient in the BIS group, compared with the ETAC group, experiencing PONV was 0.978 (95% CI, 0.642–1.492). This logistic regression had a fair C-statistic value of 0.610 and a Hosmer-Lemeshow chi-square test characteristic of 3.9 with 8 degrees of freedom (P
= 0.86), indicating that although overall model fit is fair, the numbers of PONV events are not significantly different from those predicted by the model. The multivariate logistic regression for severe postoperative pain included 602 patients (table 4
). The adjusted odds ratio for a patient in the BIS group, compared with the ETAC group, experiencing severe postoperative pain was 0.812 (95% CI, 0.562–1.172). This logistic regression had a C-statistic of 0.683 and a Hosmer-Lemeshow test characteristic of 13.7 on 8 degrees of freedom (P
= 0.09), indicating that although the overall model fit is fair, the numbers of pain events are not significantly different from those predicted by the model.
The primary aim of this analysis was to determine whether following a BIS-guided protocol rather than an ETAC-guided protocol for anesthetic administration would improve specific recovery metrics following general anesthesia in patients at high risk for intraoperative awareness, as defined by our methodology. No significant differences were found in time to PACU discharge readiness, time to achieve an Aldrete score of 9–10, ICU length of stay, incidence of PONV, or incidence of severe postoperative pain. No differences were observed even after adjusting for prognostically important patient characteristics and perioperative variables. These results differ from a report by the Cochrane Database of Systematic Reviews that found that BIS monitoring was associated with faster recovery.5
These results also contrast with the findings of several trials that found that BIS monitoring was associated with a reduced incidence of PONV.6–8
The results presented here are consistent with the B-Aware trial, in which the BIS protocol was similarly not associated with clinically relevant improved recovery compared with routine care, notwithstanding a 1-min decrease in median time to eye opening and a 3-min decrease in median time to PACU discharge.4
These results are also consistent with the recent Michigan Awareness Control Study, in which a BIS-based protocol was not associated with a clinically meaningful decrease in median time to PACU discharge readiness (95 min vs.
98 min) or reduced incidence of postoperative nausea or vomiting (7% vs.
8%) when compared with an anesthetic concentration–based protocol in a diverse surgical population.41
One possible explanation for the different results in the B-Unaware and BAG-RECALL trials compared with some previous trials might have been that the current trials included only patients at high risk for intraoperative awareness, as defined by our methodology, whereas previous trials enrolled a wider variety of patients. It is possible that BIS monitoring produces no benefit in relation to postoperative recovery among patients who are at high risk for awareness but does produce a benefit in other populations. However, the Michigan Awareness Control Study found results similar to these in a population not limited to those at high risk for awareness.41
Another possible explanation for these differences lies in the differing protocols for anesthetic administration used in these various studies. In many previous trials, patients were randomized to receive anesthesia with a BIS-guided protocol versus
routine clinical practice. Such a study design does not address the possibility that the use of a protocol of any kind to guide anesthetic management might potentially modify the anesthesiologist’s practice through promoting vigilance and potentially bias the results. In the B-Unaware and BAG-RECALL trials, the use of an ETAC-based protocol (i.e.
, a protocol-based active comparator rather than routine clinical practice) to guide anesthetic management in the control group addresses this possibility. Another possible explanation for the difference in results is that the anesthesiologists in the B-Unaware and BAG-RECALL trials were not informed that postoperative recovery parameters would be evaluated as secondary outcomes, mitigating a Hawthorne effect or other biases that could potentially be present in a small efficacy study.
It is possible that a protocol targeting BIS values between 45 and 60, as opposed to the protocols in the B-Aware, B-Unaware, and BAG-RECALL trials, which targeted BIS values between 40 and 60, would reveal the benefit of the BIS in relation to postoperative recovery. However, recent evidence suggests that the BIS value tends to a plateau value in the low 40s over a clinically relevant range of anesthetic concentrations.42–44
This is corroborated by results of several large clinical trials in which mean BIS values during anesthetic maintenance have been between 37 and 47.13
Titrating anesthetic concentration to achieve BIS values between 45 and 60 appears to be difficult to accomplish in clinical practice, although one recent large study reported a median BIS value of 53 (95% CI, 48–57) in a group managed with a BIS-guided protocol.49
Furthermore, intraoperative median BIS values were not independently associated with any of the postoperative recovery times, the incidence of severe postoperative pain, or the incidence of PONV (tables 3
). Therefore, this study does not provide evidence to support the hypothesis that maintaining higher intraoperative median BIS values leads to more rapid postoperative recovery or improved quality of recovery.
This study has several important limitations. Although no differences in any of the measures were found, the 95% CIs for several of the outcomes evaluated included clinically significant differences at the extremes. For example, the 95% CI of the NNT to prevent a case of severe postoperative pain has a lower bound of 9. Thus, this study does not exclude the possibility that clinically relevant differences between the BIS and ETAC protocols do exist in relation to recovery parameters. Both multivariate logistic regressions have fair C statistics, suggesting that some unmeasured variables have a major impact on the emergence of PONV and postoperative pain. PACU discharge readiness was measured using the hospital’s routine protocols, so it is possible that some patients waited longer than others to be assessed for discharge by the attending physician. However, the PACU staff was blinded with respect to anesthetic protocol, so any artificially prolonged times to PACU discharge readiness were probably distributed equally between the BIS and ETAC cohorts. Also, time to achieve an Aldrete score of 9 or 10 would not have been subject to this stipulation, as this time was recorded by the nurse caring for the patient in the PACU. As already mentioned, because this study included only patients who were at high risk for intraoperative awareness, applying the results to the general surgical population is not warranted. The results of this study also do not exclude the possibility that intraoperative BIS monitoring may be beneficial with respect to other outcomes. For example, the recent Cognitive Dysfunction after Anesthesia trial identified a potential role of BIS-guided anesthesia in reducing the incidence of postoperative delirium and cognitive decline.49
Finally, although practitioner bias is often a potential confounder in clinical trials, it is unlikely that the results of this study reflect practitioner bias, as many different anesthesiologists and certified registered nurse anesthetists participated over a period of nearly 5 yr.
Overall, this study advances the field by demonstrating that the use of a BIS-guided protocol rather than an ETAC-guided protocol to titrate anesthesia in patients at high risk for awareness, as defined in this study, does not result in improved anesthetic recovery as assessed by time to achieve an Aldrete score of 9–10, time to PACU discharge readiness, PONV incidence, and severe postoperative pain occurrence. Similarly, a BIS-guided protocol does not result in a shorter ICU length of stay in this population. The results of this trial contrast with meta-analyses of efficacy trials conducted by the Cochrane Database of Systematic Reviews5
but are congruent with the results of the recently reported Michigan Awareness Control Study,41
a large effectiveness trial including a diverse surgical population.
The authors thank the members of the B-Unaware and BAG-RECALL research groups, without whom this study would not have been possible.
1. Kehlet H, Dahl JB. Anaesthesia, surgery, and challenges in postoperative recovery. Lancet. 2003;362:1921–8
2. Macario A, Weinger M, Carney S, Kim A. Which clinical anesthesia outcomes are important to avoid? The perspective of patients. Anesth Analg. 1999;89:652–8
3. Dexter F, Macario A, Manberg PJ, Lubarsky DA. Computer simulation to determine how rapid anesthetic recovery protocols to decrease the time for emergence or increase the phase I postanesthesia care unit bypass rate affect staffing of an ambulatory surgery center. Anesth Analg. 1999;88:1053–63
4. Leslie K, Myles PS, Forbes A, Chan MT, Short TG, Swallow SK. Recovery from bispectral index-guided anaesthesia in a large randomized controlled trial of patients at high risk of awareness. Anaesth Intensive Care. 2005;33:443–51
5. Punjasawadwong Y, Phongchiewboon A, Bunchungmongkol N. Bispectral index for improving anaesthetic delivery and postoperative recovery. Cochrane Database Syst Rev 2007.;(4):CD003843
6. Leslie K, Myles PS, Chan MT, Paech MJ, Peyton P, Forbes A, McKenzie DENIGMA Trial Group. . Risk factors for severe postoperative nausea and vomiting in a randomized trial of nitrous oxide-based vs nitrous oxide-free anaesthesia. Br J Anaesth. 2008;101:498–505
7. Satisha M, Sanders GM, Badrinath MR, Ringer JM, Morley AP. Introduction of bispectral index monitoring in a district general hospital operating suite: A prospective audit of clinical and economic effects. Eur J Anaesthesiol. 2010;27:196–201
8. Liu SS. Effects of Bispectral Index monitoring on ambulatory anesthesia: A meta-analysis of randomized controlled trials and a cost analysis. ANESTHESIOLOGY. 2004;101:311–5
9. Sahni N, Anand LK, Gombar K, Gombar S. Effect of intraoperative depth of anesthesia on postoperative pain and analgesic requirement: A randomized prospective observer blinded study. J Anaesthesiol Clin Pharmacol. 2011;27:500–5
10. Recart A, Gasanova I, White PF, Thomas T, Ogunnaike B, Hamza M, Wang A. The effect of cerebral monitoring on recovery after general anesthesia: A comparison of the auditory evoked potential and bispectral index devices with standard clinical practice. Anesth Analg. 2003;97:1667–74
11. Sieber FE, Zakriya KJ, Gottschalk A, Blute MR, Lee HB, Rosenberg PB, Mears SC. Sedation depth during spinal anesthesia and the development of postoperative delirium in elderly patients undergoing hip fracture repair. Mayo Clin Proc. 2010;85:18–26
12. Lat I, McMillian W, Taylor S, Janzen JM, Papadopoulos S, Korth L, Ehtisham A, Nold J, Agarwal S, Azocar R, Burke P. The impact of delirium on clinical outcomes in mechanically ventilated surgical and trauma patients. Crit Care Med. 2009;37:1898–905
13. Myles PS, Leslie K, McNeil J, Forbes A, Chan MT. Bispectral index monitoring to prevent awareness during anaesthesia: The B-Aware randomised controlled trial. Lancet. 2004;363:1757–63
14. Klopman MA, Sebel PS. Cost-effectiveness of bispectral index monitoring. Curr Opin Anaesthesiol. 2011;24:177–81
15. Avidan MS, Zhang L, Burnside BA, Finkel KJ, Searleman AC, Selvidge JA, Saager L, Turner MS, Rao S, Bottros M, Hantler C, Jacobsohn E, Evers AS. Anesthesia awareness and the bispectral index. N Engl J Med. 2008;358:1097–108
16. Avidan MS, Jacobsohn E, Glick D, Burnside BA, Zhang L, Villafranca A, Karl L, Kamal S, Torres B, O’Connor M, Evers AS, Gradwohl S, Lin N, Palanca BJ, Mashour GABAG-RECALL Research Group. . Prevention of intraoperative awareness in a high-risk surgical population. N Engl J Med. 2011;365:591–600
17. Nickalls RW, Mapleson WW. Age-related iso-MAC charts for isoflurane, sevoflurane and desflurane in man. Br J Anaesth. 2003;91:170–4
18. Aldrete JA, Kroulik D. A postanesthetic recovery score. Anesth Analg. 1970;49:924–34
19. Kalkman CJ, Visser K, Moen J, Bonsel GJ, Grobbee DE, Moons KG. Preoperative prediction of severe postoperative pain. Pain. 2003;105:415–23
20. Babyak MA. What you see may not be what you get: A brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med. 2004;66:411–21
21. Buchanan FF, Myles PS, Cicuttini F. Effect of patient sex on general anaesthesia and recovery. Br J Anaesth. 2011;106:832–9
22. Atoui R, Ma F, Langlois Y, Morin JF. Risk factors for prolonged stay in the intensive care unit and on the ward after cardiac surgery. J Card Surg. 2008;23:99–106
23. Reinikainen M, Niskanen M, Uusaro A, Ruokonen E. Impact of gender on treatment and outcome of ICU patients. Acta Anaesthesiol Scand. 2005;49:984–90
24. Higgins TL, McGee WT, Steingrub JS, Rapoport J, Lemeshow S, Teres D. Early indicators of prolonged intensive care unit stay: Impact of illness severity, physician staffing, and pre-intensive care unit length of stay. Crit Care Med. 2003;31:45–51
25. Apfel CC, Läärä E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: Conclusions from cross-validations between two centers. ANESTHESIOLOGY. 1999;91:693–700
26. Sinclair DR, Chung F, Mezei G. Can postoperative nausea and vomiting be predicted? ANESTHESIOLOGY. 1999;91:109–18
27. Mei W, Seeling M, Franck M, Radtke F, Brantner B, Wernecke KD, Spies C. Independent risk factors for postoperative pain in need of intervention early after awakening from general anaesthesia. Eur J Pain. 2010;14:149.e1–7
28. Ghotkar SV, Grayson AD, Fabri BM, Dihmis WC, Pullan DM. Preoperative calculation of risk for prolonged intensive care unit stay following coronary artery bypass grafting. J Cardiothorac Surg. 2006;1:14
29. Huang YC, Huang SJ, Tsauo JY, Ko WJ. Definition, risk factors and outcome of prolonged surgical intensive care unit stay. Anaesth Intensive Care. 2010;38:500–5
30. Rosenfeld R, Smith JM, Woods SE, Engel AM. Predictors and outcomes of extended intensive care unit length of stay in patients undergoing coronary artery bypass graft surgery. J Card Surg. 2006;21:146–50
31. Ip HY, Abrishami A, Peng PW, Wong J, Chung F. Predictors of postoperative pain and analgesic consumption: A qualitative systematic review. ANESTHESIOLOGY. 2009;111:657–77
32. Seago JA, Weitz S, Walczak S. Factors influencing stay in the postanesthesia care unit: A prospective analysis. J Clin Anesth. 1998;10:579–87
33. Waddle JP, Evers AS, Piccirillo JF. Postanesthesia care unit length of stay: Quantifying and assessing dependent factors. Anesth Analg. 1998;87:628–33
34. Truong L, Moran JL, Blum P. Post anaesthesia care unit discharge: A clinical scoring system versus traditional time-based criteria. Anaesth Intensive Care. 2004;32:33–42
35. Aubrun F, Valade N, Coriat P, Riou B. Predictive factors of severe postoperative pain in the postanesthesia care unit. Anesth Analg. 2008;106:1535–41
36. Tramèr MR, Fuchs-Buder T. Omitting antagonism of neuromuscular block: Effect on postoperative nausea and vomiting and risk of residual paralysis. A systematic review. Br J Anaesth. 1999;82:379–86
37. Apfel CC, Korttila K, Abdalla M, Kerger H, Turan A, Vedder I, Zernak C, Danner K, Jokela R, Pocock SJ, Trenkler S, Kredel M, Biedler A, Sessler DI, Roewer NIMPACT Investigators. . A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med. 2004;350:2441–51
38. Pereira J, Berry Otfinowski P, Hagen N, Bruera E, Fainsinger R, Summers N Alberta Hospice Palliative Care Resource Manual, 2nd edition. 2001 Calgary, AB, Canada Alberta Cancer Board
39. Cusick JM Anesthesia & Critical Care Reference Sheet. 2009 Goodyear, AZ Jeffery Cusick
40. Golembiewski J, Chernin E, Chopra T. Prevention and treatment of postoperative nausea and vomiting. Am J Health Syst Pharm. 2005;62:1247–60; quiz 1261–2
41. Mashour GA, Shanks A, Tremper KK, Kheterpal S, Turner CR, Ramachandran SK, Picton P, Schueller C, Morris M, Vandervest JC, Lin N, Avidan MS. Prevention of intraoperative awareness with explicit recall in an unselected surgical population: A randomized comparative effectiveness trial. ANESTHESIOLOGY. 2012;117:717–25
42. Whitlock EL, Villafranca AJ, Lin N, Palanca BJ, Jacobsohn E, Finkel KJ, Zhang L, Burnside BA, Kaiser HA, Evers AS, Avidan MS. Relationship between bispectral index values and volatile anesthetic concentrations during the maintenance phase of anesthesia in the B-Unaware trial. ANESTHESIOLOGY. 2011;115:1209–18
43. Kreuer S, Bruhn J, Ellerkmann R, Ziegeler S, Kubulus D, Wilhelm W. Failure of two commercial indexes and spectral parameters to reflect the pharmacodynamic effect of desflurane on EEG. J Clin Monit Comput. 2008;22:149–58
44. Kreuer S, Bruhn J, Walter E, Larsen R, Apfel CC, Grundmann U, Biedler A, Wilhelm W. Comparative pharmacodynamic modeling using bispectral and narcotrend-index with and without a pharmacodynamic plateau during sevoflurane anesthesia. Anesth Analg. 2008;106:1171–81
45. Ekman A, Lindholm ML, Lennmarken C, Sandin R. Reduction in the incidence of awareness using BIS monitoring. Acta Anaesthesiol Scand. 2004;48:20–6
46. Pavlin JD, Souter KJ, Hong JY, Freund PR, Bowdle TA, Bower JO. Effects of bispectral index monitoring on recovery from surgical anesthesia in 1,580 inpatients from an academic medical center. ANESTHESIOLOGY. 2005;102:566–73
47. Leslie K, Skrzypek H, Paech MJ, Kurowski I, Whybrow T. Dreaming during anesthesia and anesthetic depth in elective surgery patients: A prospective cohort study. ANESTHESIOLOGY. 2007;106:33–42
48. Lindholm ML, Brudin L, Sandin RH. Bispectral index monitoring: Appreciated but does not affect drug dosing and hypnotic levels. Acta Anaesthesiol Scand. 2008;52:88–94
49. Chan MT, Cheng BC, Lee TM, Gin TCODA Trial Group. . BIS-guided anesthesia decreases postoperative delirium and cognitive decline. J Neurosurg Anesthesiol. 2013;25:33–42
© 2013 American Society of Anesthesiologists, Inc.
Publication of an advertisement in Anesthesiology Online does not constitute endorsement by the American Society of Anesthesiologists, Inc. or Lippincott Williams & Wilkins, Inc. of the product or service being advertised.